Registry of Lobbyists
| Corporation: | Lafitte Ventures Ltd., dba Tilray |
| Associated registration: | 909715-344506-1 |
| Communication date: | 2016-01-07 |
| Posted date: | 2016-01-11 |
| Designated Public Office Holders who participated in the communication: |
Eric Costen,
Executive Director
Office of Medical Cannabis, Health Canada (HC) Chris Rose, Director of Operations Office of Medical Cannabis, Health Canada (HC) |
| Subject Matter of the communication: | Consumer Issues, Health, Research and Development |
| Responsible Officer who filed this communication report: | Gregory Engel |
| As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed. | |